undefined undefined
NaN.000
NaN.00%
Evaxion Biotech A/S Adr (EVAX) has released an update. Evaxion Biotech A/S, als...
04-26 06:27
Evaxion Biotech A/S Adr (EVAX) has released an update. Evaxion Biotech A/S has ...
03-29 21:57
Evaxion Biotech ADS press release (EVAX): FY GAAP EPS of -$0.81. As of December 31, 2023, cash and cash equivalents were $5.6 million compared to $13.2 as of December 31, 2022. More on Evaxion Biotech...
03-28 01:49
Evaxion Biotech A/S Adr (EVAX) has released an update. Evaxion Biotech A/S has ...
03-27 23:29
Evaxion Biotech (NASDAQ:EVAX) reported its Q4 earnings results on Wednesday, Ma...
03-27 21:35
Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(1.60) by 90 percent. This is a 94.48 percent increase over losses of $(2.90) per share from the
03-27 19:34
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion Biotech (NASDAQ:EVAX) with a Buy and maintains $14 price target.
03-20 18:54
Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that on February 05, 2024, it received a
02-07 21:34
①丹麦科技生物公司Evaxion Biotech A/S宣布将针对新型肿瘤抗原(内源性逆转录病毒,ERV)开发定制癌症疫苗; ②新闻稿写道,Evaxion通过公司的人工智能技术平台“AI-Immunology”发现了这些新型的ERV癌症疫苗靶点。
01-30 00:05